September 26, 2007

Imugene expands vaccine developments

Imugene Ltd announced it has substantially expanded its vaccine developments based on the increasing productivity of its La Trobe University laboratory and US trial facility.

The expanded program includes two new poultry vaccines and two new avian influenza vaccines for H7 and H9 virus strains to complement the successful H5 avian influenza vaccine.